Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model
Susan L. Baldwin, Valerie A. Reese, Sasha E. Larsen, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0247990-e0247990
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
Zhuang Li, Ling Yang, Linsheng Li, et al.
MedComm (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 20
In silico design of a promiscuous chimeric multi-epitope vaccine against Mycobacterium tuberculosis
Binda T. Andongma, Yazheng Huang, Fang Chen, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 991-1004
Open Access | Times Cited: 26
Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosis
Guneswar Sethi, Rinku Polachirakkal Varghese, Avinash Kant Lakra, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Engineered macromolecular Toll-like receptor agents and assemblies
Brooke A. Jackson Hoffman, Elizabeth A. Pumford, Amaka I. Enueme, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 9, pp. 1139-1154
Open Access | Times Cited: 15
The Research Progress in Immunotherapy of Tuberculosis
Jie Mi, Yan Liang, Jianqin Liang, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 28
Immunological effects of the PE/PPE family proteins of Mycobacterium tuberculosis and related vaccines
Fangzheng Guo, Jing Wei, Yamin Song, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Lyophilization Strategy Enhances the Thermostability and Field-Based Stability of Conjugated and Comixed Subunit Liposomal Adjuvant-containing Tuberculosis Vaccine Formulation (ID93 + GLA-LSQ)
Babatunde Ayodeji Adeagbo, M. J. Alao, Ochuko M. Orherhe, et al.
Molecular Pharmaceutics (2025)
Closed Access
Characterizing TLR4 agonist EmT4™ as an anti-Mycobacterium tuberculosis vaccine adjuvant
Sasha E. Larsen, Maham Rais, Valerie A. Reese, et al.
ImmunoHorizons (2025) Vol. 9, Iss. 6
Open Access
Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Yu Hwa Choi, Young Ae Kang, Kwang Joo Park, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 6, pp. 1605-1624
Open Access | Times Cited: 8
A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination
Zhidong Hu, Jianping Chen, Jinchuan Xu, et al.
Virology (2021) Vol. 566, pp. 56-59
Open Access | Times Cited: 17
Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen
Maham Rais, Hazem F. M. Abdelaal, Valerie A. Reese, et al.
Tuberculosis (2022) Vol. 138, pp. 102302-102302
Open Access | Times Cited: 12
Promotion of Th17 Polarized Immunity via Co-Delivery of Mincle Agonist and Tuberculosis Antigen Using Silica Nanoparticles
Walid Abdelwahab, Bao Le‐Vinh, Alexander Riffey, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 6, pp. 3877-3889
Closed Access | Times Cited: 2
Therapeutic efficacy against Mycobacterium tuberculosis using ID93 and liposomal adjuvant formulations
Susan L. Baldwin, Valerie A. Reese, Sasha E. Larsen, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 11
Therapeutic Potentials of Immunometabolomic Modulations Induced by Tuberculosis Vaccination
Bhupendra Singh Rawat, Deepak Kumar, Vijay Soni, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 2127-2127
Open Access | Times Cited: 9
Construction and evaluation of a novel multi-antigenic Mycobacterium tuberculosis subunit vaccine candidate BfrB-GrpE/DPC
Hongxia Niu, Qianqian Cao, Tingting Zhang, et al.
International Immunopharmacology (2023) Vol. 124, pp. 111060-111060
Closed Access | Times Cited: 4
The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination
R.Y. Valdivia-Olivares, María Rodriguez-Fernández, María Javiera Álvarez-Figueroa, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1420-1420
Open Access | Times Cited: 8
Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG
Lirong Mao, Jianpeng Du, Xiaochun Wang, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 3, pp. 593-608
Closed Access | Times Cited: 3
Non-clinical evaluation of local and systemic immunity induced by different vaccination strategies of the candidate tuberculosis vaccine M72/AS01
Nadia Ouaked, Marie‐Ange Demoitié, Fabrice Godfroid, et al.
Tuberculosis (2023) Vol. 143, pp. 102425-102425
Open Access | Times Cited: 2
Construction and expression of Mycobacterium tuberculosis fusion protein SHR3 and its immunogenicity analysis in combination with various adjuvants
Zian Zhang, Lifa Xu, Xiaochun Wang, et al.
Tuberculosis (2024) Vol. 145, pp. 102480-102480
Closed Access
Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humans
Andrew Fioré-Gartland, Himangi Srivastava, Aaron Seese, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Progress in the Development of New Vaccines Against Tuberculosis
Emma Whitlow, Abu Salim Mustafa, Shumaila Nida Muhammad Hanif
Springer eBooks (2023), pp. 211-232
Closed Access | Times Cited: 1
Immunogenic profiling of Mycobacterium tuberculosis Rv1513 reveals its ability to switch on Th1 based immunity
Zilun Shi, Lili Zhou, Xiaochun Wang, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 8
Closed Access
Adjuvants, immunomodulators, and adaptogens
Anita Milicic, Sören Reinke, Joannah R. Fergusson, et al.
Elsevier eBooks (2022), pp. 223-280
Closed Access | Times Cited: 2
Adjuvants influence the maturation of VRC01-like antibodies during immunization
Maria L. Knudsen, Parul Agrawal, Anna J. MacCamy, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105473-105473
Open Access | Times Cited: 2
Construction and expression of Mycobacterium tuberculosis fusion protein AR2 and its immunogenicity in combination with various adjuvants to form vaccine
Xiaochun Wang, Jianpeng Du, Yanpeng Zhang, et al.
Tuberculosis (2022) Vol. 137, pp. 102270-102270
Closed Access
Page 1 - Next Page

Scroll to top